An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma

Baxter, M.A., Spender, L.C., Cairns, D. orcid.org/0000-0002-2338-0179 et al. (20 more authors) (2024) An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma. ESMO Open, 9 (5). 103450. ISSN 2059-7029

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 The Authors. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: gastroesophageal adenocarcinoma, DNA damage immune response, immune checkpoint inhibitors, epidermal growth factor receptor, tumour microenvironment
Dates:
  • Published: May 2024
  • Published (online): 13 May 2024
  • Accepted: 5 April 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics
Depositing User: Symplectic Publications
Date Deposited: 05 Jul 2024 14:00
Last Modified: 05 Jul 2024 14:00
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.esmoop.2024.103450
Related URLs:
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics